Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

374 ARTÍCULOS , VIENDO DEL 196 AL 210

A Black Alzheimer's Patient Wants To Be Part Of The Cure

Gray K.

Health Aff (Millwood). 2017 Jun 1;36(6):1129-1132. doi: 10.1377/hlthaff.2017.0296.

Strengthening the Case for Epilepsy Drug Development: Bridging Experiences from the Alzheimer's Disease Field-An Opinion

Twyman RE.

Neurochem Res. 2017 Jul;42(7):2099-2115. doi: 10.1007/s11064-017-2300-2. Epub 2017 Jun 7.

DPP4 Inhibitors Can Be a Drug of Choice for Type 3 Diabetes: A Mini Review

Chalichem NSS, Gonugunta C, Krishnamurthy PT, Duraiswamy B.

Am J Alzheimers Dis Other Demen. 2017 Nov;32(7):444-451. doi: 10.1177/1533317517722005. Epub 2017 Jul 27.

Vitamin B12 in Association with Antipsychotic Drugs Can Modulate the Expression of Pro-/Anti-Inflammatory Cytokines in Alzheimer Disease Patients

Vakilian A, Razavi-Nasab SM, Ravari A, Mirzaei T, Moghadam-Ahmadi A, Jalali N, Bahramabadi R, Rezayati M, Yazdanpanah-Ravari A, Bahmaniar F, Bagheri MR, Sheikh Fathollahi M, Asadikaram G, Kazemi Arababadi M.

Neuroimmunomodulation. 2017;24(6):310-319. doi: 10.1159/000486597. Epub 2018 Mar 20.

Beyond Acetylcholinesterase Inhibitors: Novel Cholinergic Treatments for Alzheimer's Disease

Kamkwalala AR, Newhouse PA.

Curr Alzheimer Res. 2017;14(4):377-392. doi: 10.2174/1567205013666160930112625.

[Memantine as add-on medication to acetylcholinesterase inhibitor therapy for Alzheimer dementia]

Haussmann R, Donix M.

Nervenarzt. 2017 Jan;88(1):40-45. doi: 10.1007/s00115-016-0237-3.

Repetitive transcranial magnetic stimulation improves cognitive function of Alzheimer's disease patients

Zhao J, Li Z, Cong Y, Zhang J, Tan M, Zhang H, Geng N, Li M, Yu W, Shan P.

Oncotarget. 2017 May 16;8(20):33864-33871. doi: 10.18632/oncotarget.13060.

Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors

Lee SJ, Nam E, Lee HJ, Savelieff MG, Lim MH.

Chem Soc Rev. 2017 Jan 23;46(2):310-323. doi: 10.1039/c6cs00731g.

Alzheimer's disease and other dementias: update on research

Schneider L.

Lancet Neurol. 2017 Jan;16(1):4-5. doi: 10.1016/S1474-4422(16)30356-8.

Current opinion in Alzheimer's disease therapy by nanotechnology-based approaches

Ansari SA, Satar R, Perveen A, Ashraf GM.

Curr Opin Psychiatry. 2017 Mar;30(2):128-135. doi: 10.1097/YCO.0000000000000310.

The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial

Carotenuto A, Rea R, Traini E, Fasanaro AM, Ricci G, Manzo V, Amenta F.

J Alzheimers Dis. 2017;56(2):805-815. doi: 10.3233/JAD-160675.

Insulin Resistance in Alzheimer Disease: p53 and MicroRNAs as Important Players

Gasiorowski K, Brokos B, Leszek J, Tarasov VV, Ashraf GM, Aliev G.

Curr Top Med Chem. 2017;17(12):1429-1437. doi: 10.2174/1568026617666170103161233.

Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease

Moussa C, Hebron M, Huang X, Ahn J, Rissman RA, Aisen PS, Turner RS.

J Neuroinflammation. 2017 Jan 3;14(1):1. doi: 10.1186/s12974-016-0779-0.

A Perspective on Crocus sativus L. (Saffron) Constituent Crocin: A Potent Water-Soluble Antioxidant and Potential Therapy for Alzheimer's Disease

Finley JW, Gao S.

J Agric Food Chem. 2017 Feb 8;65(5):1005-1020. doi: 10.1021/acs.jafc.6b04398. Epub 2017 Jan 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias